Latest Balance Sheet News

Swift Networks reports positive FY25 cash flow and EBITDA, secures new mining contracts, and progresses its next-generation Swift Access 2026 platform poised to accelerate growth.

Cann Group Limited delivered record production and revenue growth in Q4 FY2025, securing new funding and advancing a major debt restructuring to set the stage for profitability in FY2026.

Tasman Resources progresses exploration at Lake Torrens and Parkinson Dam projects while managing capital through a recent entitlement offer and loan repayments.

Eden Innovations reports a striking 114% year-on-year jump in Q4 US sales of its EdenCrete® products, alongside a 50% annual sales increase and significant debt reduction plans.

Freehill Mining reported a transitional quarter marked by a dip in sales due to project cycles but offset by strategic site acquisitions and a successful capital raise. The company is poised for growth with new processing sites and promising magnetite test results.

Cambium Bio has cleared key regulatory hurdles for its lead dry eye disease treatment, Elate Ocular, and strengthened its balance sheet with a $2.12 million placement to support upcoming Phase 3 trials.

Savannah Goldfields is advancing plans to resume gold production at its Georgetown processing plant and Big Reef mine, capitalizing on gold prices above A$5000 per ounce. The company also unveiled new exploration targets and key executive appointments to drive growth.

Tombador Iron Limited reported a solid cash position of AUD 9.549 million as it advances the acquisition of the Colomi Iron Project in Brazil, while navigating royalty income challenges and preparing for a capital raise.

Northern Minerals Limited reported a $5.1 million cash outflow from operations in the June quarter but bolstered its balance sheet with a $42.4 million equity raise, ending the period with $24.3 million in cash.

Great Boulder Resources reports a busy quarter with extensive drilling at Side Well and a robust scoping study at Ironbark, highlighting strong project economics and a recent $12.5 million capital raise.

Hydralyte USA reported an 8.5% rise in Q2 FY25 net sales, driven by strong May performance and improved margins, while preparing to launch new brain and gut health products.

Hartshead Resources NL reports steady progress on its P2607 gas development in the UK Southern North Sea, supported by a strong cash position and ongoing joint venture negotiations with RockRose Energy.